To determine the role of this TP53 variant in the pathogenesis of breast cancer, we first crossed p53+/C mice with mice expressing the polyoma virus middle T antigen (PyVT) driven by the mouse mammary tumor virus long terminal repeat (MMTV) promoter in the mammary gland36. This evidence concerns the gene TP53 and breast carcinoma.